biotech peptides retatrutide The trillion-dollar peptide. Appearing on @tbpn, Andrew Huberman said could be the peptide that “changes everything.” Now in Phase III clinical trials, it's shown up to 30% body weight loss in Retatrutide 20mg | Triple GIP/GLP-1/Glucagon

There is no published evidence linking oral NAD+ supplementation to significant weight loss or GLP-1 production

Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease

In healthy non-pregnant women, it can take up to 6 weeks, on average, for most of the GLP-1s to be gone from the body

Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity